Iconic Brands, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000147793223002106 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$212.6K	$916.5K	$916.5K
YoY Change	-97.2%	-58.16%	-58.16%
Cash & Equivalents	$212.6K	$916.5K
Short-Term Investments
Other Short-Term Assets	$545.6K	$550.5K	$550.5K
YoY Change	3.31%	638.7%	638.7%
Inventory	$1.435M	$1.555M	$1.555M
Prepaid Expenses
Receivables	$1.058M	$1.302M	$1.302M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.252M	$4.324M	$4.324M
YoY Change	-78.79%	-0.51%	-0.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.54M	$7.462M	$12.55M
YoY Change	71.54%	34.29%	45.38%
Goodwill		$0.00
YoY Change		-100.0%
Intangibles	$1.009M	$1.085M
YoY Change	-95.15%	-94.98%
Long-Term Investments
YoY Change
Other Assets	$398.1K	$400.5K	$400.5K
YoY Change	77.89%	181.3%	181.3%
Total Long-Term Assets	$13.95M	$14.03M	$14.03M
YoY Change	-72.0%	-69.73%	-69.73%
TOTAL ASSETS
Total Short-Term Assets	$3.252M	$4.324M	$4.324M
Total Long-Term Assets	$13.95M	$14.03M	$14.03M
Total Assets	$17.20M	$18.36M	$18.36M
YoY Change	-73.59%	-63.79%	-63.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.897M	$5.111M	$5.372M
YoY Change	74.73%	273.68%	98.0%
Accrued Expenses	$2.454M	$2.211M	$2.211M
YoY Change	336.44%	481.06%	481.06%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$5.162M	$5.162M
YoY Change	-100.0%	2.31%	2.31%
Long-Term Debt Due	$5.618M
YoY Change
Total Short-Term Liabilities	$14.35M	$12.98M	$12.98M
YoY Change	16.39%	-22.05%	-22.05%
LONG-TERM LIABILITIES
Long-Term Debt	$229.7K	$262.8K	$262.8K
YoY Change	56.23%	78.75%	78.75%
Other Long-Term Liabilities	$4.592M	$4.757M	$4.757M
YoY Change	-81.94%	-67.85%	-67.85%
Total Long-Term Liabilities	$4.822M	$5.019M	$5.019M
YoY Change	-81.15%	-66.41%	-66.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.35M	$12.98M	$12.98M
Total Long-Term Liabilities	$4.822M	$5.019M	$5.019M
Total Liabilities	$18.52M	$18.00M	$17.20M
YoY Change	-51.14%	-43.03%	-44.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$73.68M	-$70.99M
YoY Change		92.07%
Common Stock	$107.6K	$107.3K
YoY Change	10.82%	18.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.317M	$360.2K	$1.161M
YoY Change
Total Liabilities & Shareholders Equity	$17.20M	$18.36M	$18.36M
YoY Change	-73.59%	-63.79%	-63.79%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Inventory Net InventoryNet	1228351	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	550482	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	74517	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4323876	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	4346003	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5086989	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3074864	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5556964	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19113055	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50706656	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	852321	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	189195	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	135034	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4756660	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2835828	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	262759	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	147001	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2190814	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7462219	usd
CY2022Q4	icnb	Factoring Liability Current FactoringLiabilityCurrent	93249	usd
CY2021Q4	icnb	Factoring Liability Current FactoringLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	-765227	usd
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001350073
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107276138	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	90542764	shares
CY2021Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	11959863	usd
CY2022	icnb	Earn Out Amount Second Year EarnOutAmountSecondYear	11959863	usd
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	10143744	usd
CY2022	icnb	Gain From The Change In Fair Value Of Contingent Consideration GainFromTheChangeInFairValueOfContingentConsideration	12984661	usd
CY2021	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.1	pure
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-53162
CY2022	dei	Entity Registrant Name EntityRegistrantName	Iconic Brands, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-4362274
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	44 Seabro Avenue
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Amityville
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11701
CY2022	dei	City Area Code CityAreaCode	631
CY2022	dei	Local Phone Number LocalPhoneNumber	464-4050
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022	dei	Trading Symbol TradingSymbol	ICNB
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	12125000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	107596138	shares
CY2022	dei	Auditor Name AuditorName	Mazars USA LLP
CY2022	dei	Auditor Location AuditorLocation	Fort Washington, PA
CY2022	dei	Auditor Firm AuditorFirmId	339
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	916526	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1302175	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1554693	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1085200	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21609586	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
CY2021Q4	us-gaap	Goodwill Goodwill	15976877	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	400464	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	142362	usd
CY2022Q4	us-gaap	Assets Assets	18358748	usd
CY2021Q4	us-gaap	Assets Assets	50706656	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6912440	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2713046	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	5068915	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	5045466	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	45000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	132234	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	670288	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	380487	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	8244642	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12979087	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16650909	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	11959863	usd
CY2022Q4	us-gaap	Liabilities Liabilities	17998506	usd
CY2021Q4	us-gaap	Liabilities Liabilities	31593601	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	38	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	27	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	107276138	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	90542764	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	107277	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	90544	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	72045951	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56749055	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-70992412	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36961344	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-800612	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	360242	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18358748	usd
CY2022	us-gaap	Revenues Revenues	14745261	usd
CY2021	us-gaap	Revenues Revenues	4960016	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	11213269	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	4628734	usd
CY2022	us-gaap	Gross Profit GrossProfit	3531992	usd
CY2021	us-gaap	Gross Profit GrossProfit	331282	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19412328	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10453730	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1036620	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	716727	usd
CY2022	icnb	Gain From The Cancellation Of Accrued Royalties GainFromTheCancellationOfAccruedRoyalties	0	usd
CY2021	icnb	Gain From The Cancellation Of Accrued Royalties GainFromTheCancellationOfAccruedRoyalties	-577590	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	20448948	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	10592867	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-16916956	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-10261585	usd
CY2022	icnb	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	20204505	usd
CY2021	icnb	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	15976877	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	-17337933	usd
CY2022	icnb	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPppLoan	0	usd
CY2021	icnb	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPppLoan	28458	usd
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	792833	usd
CY2021	us-gaap	Interest And Debt Expense InterestAndDebtExpense	271749	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	13647	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13889491	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-243291	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-30806447	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-10504876	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-35385	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-40882	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-30771062	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-10463994	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3260006	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	usd
CY2022	icnb	Net Loss Attributable To Common And Preferred Shareholders NetLossAttributableToCommonAndPreferredShareholders	-34031068	usd
CY2021	icnb	Net Loss Attributable To Common And Preferred Shareholders NetLossAttributableToCommonAndPreferredShareholders	-10463994	usd
CY2022	icnb	Earnings Per Share Basics And Diluted EarningsPerShareBasicsAndDiluted	-0.34
CY2021	icnb	Earnings Per Share Basics And Diluted EarningsPerShareBasicsAndDiluted	-0.22
CY2022	icnb	Weighted Average Number Of Share Outstanding Basics And Diluted WeightedAverageNumberOfShareOutstandingBasicsAndDiluted	101060758	shares
CY2021	icnb	Weighted Average Number Of Share Outstanding Basics And Diluted WeightedAverageNumberOfShareOutstandingBasicsAndDiluted	48378549	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1828123	usd
CY2021	icnb	Common Stock And Series A2 Preferred Stock Issued For Cash Net Of Fees Amount CommonStockAndSeriesA2PreferredStockIssuedForCashNetOfFeesAmount	15603385	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2469592	usd
CY2021	icnb	Common Stock Issued To Purchase Toppop Amount CommonStockIssuedToPurchaseToppopAmount	10143744	usd
CY2021	icnb	Common Stock Issued For The Exchange Of Series A Preferred Stock Amount CommonStockIssuedForTheExchangeOfSeriesAPreferredStockAmount	0	usd
CY2021	icnb	Common And Preferred Shares Issued In Exchange For Old Series Ef And G Preferred Shares Amount CommonAndPreferredSharesIssuedInExchangeForOldSeriesEFAndGPreferredSharesAmount	0	usd
CY2021	icnb	Redemption Of Series F Preferred Stock Amount RedemptionOfSeriesFPreferredStockAmount	-225000	usd
CY2021	icnb	Purchase Of United Spirits PurchaseOfUnitedSpirits	-1000000	usd
CY2021	icnb	Common Stock Issued To Settle Notes Payable Amount CommonStockIssuedToSettleNotesPayableAmount	4438708	usd
CY2021	icnb	Shares Issued In Exchange For Old Warrants Amount SharesIssuedInExchangeForOldWarrantsAmount	0	usd
CY2021	icnb	Retirement Of Treasury Stock Amount RetirementOfTreasuryStockAmount	0	usd
CY2021	icnb	Exercise Of Warrants Amount ExerciseOfWarrantsAmount	15625	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-10504876	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19113055	usd
CY2022	icnb	Common Stock And Series A2 Preferred Stock Issued For Cash Net Of Fees Amount CommonStockAndSeriesA2PreferredStockIssuedForCashNetOfFeesAmount	10998076	usd
CY2022	icnb	Conversion Of Series A2 Preferred Stock For Common Stock Amount ConversionOfSeriesA2PreferredStockForCommonStockAmount	0	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1055558	usd
CY2022	icnb	Stock Dividend Issued On Series A2 Preferred Stock Amount StockDividendIssuedOnSeriesA2PreferredStockAmount	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-30806447	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	360242	usd
CY2022	us-gaap	Profit Loss ProfitLoss	30806447	usd
CY2021	us-gaap	Profit Loss ProfitLoss	10504876	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	804696	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	119746	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	605349	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	283256	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	30032	usd
CY2022	icnb	Gain On Forgiveness Of Ppp Loan On GainOnForgivenessOfPppLoanOn	0	usd
CY2021	icnb	Gain On Forgiveness Of Ppp Loan On GainOnForgivenessOfPppLoanOn	28458	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	747141	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2022	icnb	Provision For Excess And Obsolete Inventory ProvisionForExcessAndObsoleteInventory	40000	usd
CY2021	icnb	Provision For Excess And Obsolete Inventory ProvisionForExcessAndObsoleteInventory	0	usd
CY2022	icnb	Amortization Of Intangibles AmortizationOfIntangibles	3186453	usd
CY2021	icnb	Amortization Of Intangibles AmortizationOfIntangibles	1327614	usd
CY2022	icnb	Equity Compensation EquityCompensation	1055558	usd
CY2021	icnb	Equity Compensation EquityCompensation	2469592	usd
CY2022	icnb	Gainloss From The Cancellation Of Accrued Royalties GainlossFromTheCancellationOfAccruedRoyalties	0	usd
CY2021	icnb	Gainloss From The Cancellation Of Accrued Royalties GainlossFromTheCancellationOfAccruedRoyalties	577590	usd
CY2022	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	20204505	usd
CY2021	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	15976877	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	-17337933	usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1196995	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4914745	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	366342	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-474085	usd
CY2022	icnb	Increase Decrease In Operating Lease Liabilities1 IncreaseDecreaseInOperatingLeaseLiabilities1	-406841	usd
CY2021	icnb	Increase Decrease In Operating Lease Liabilities1 IncreaseDecreaseInOperatingLeaseLiabilities1	-145571	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4199394	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2240393	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	475965	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-57012	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	258102	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	142362	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-87234	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	132234	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	54161	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-259725	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9794869	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4090659	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	3694273	usd
CY2022	icnb	Cash Paid For Acquisition Of United Spirits CashPaidForAcquisitionOfUnitedSpirits	0	usd
CY2021	icnb	Cash Paid For Acquisition Of United Spirits CashPaidForAcquisitionOfUnitedSpirits	1000000	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2519968	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	3536633	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2519968	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8230906	usd
CY2022	icnb	Common Stock And Series A2 Preferred Stock Issued For Cash Net Of Fees CommonStockAndSeriesA2PreferredStockIssuedForCashNetOfFees	10998076	usd
CY2021	icnb	Common Stock And Series A2 Preferred Stock Issued For Cash Net Of Fees CommonStockAndSeriesA2PreferredStockIssuedForCashNetOfFees	15603385	usd
CY2022	icnb	Net Proceeds From Factoring Arrangement NetProceedsFromFactoringArrangement	93249	usd
CY2021	icnb	Net Proceeds From Factoring Arrangement NetProceedsFromFactoringArrangement	0	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	976708	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	50776	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2315380	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	15625	usd
CY2022	icnb	Redemption Of Series F Preferred Stock RedemptionOfSeriesFPreferredStock	0	usd
CY2021	icnb	Redemption Of Series F Preferred Stock RedemptionOfSeriesFPreferredStock	-225000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11040549	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14055338	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1274288	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1733773	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2190814	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	457041	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	916526	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2190814	usd
CY2022	us-gaap	Interest Paid InterestPaid	309767	usd
CY2021	us-gaap	Interest Paid InterestPaid	0	usd
CY2022	icnb	Common And Preferred Shares Issued In Exchange For Old Series Ef And G Preferred Shares CommonAndPreferredSharesIssuedInExchangeForOldSeriesEFAndGPreferredShares	0	usd
CY2021	icnb	Common And Preferred Shares Issued In Exchange For Old Series Ef And G Preferred Shares CommonAndPreferredSharesIssuedInExchangeForOldSeriesEFAndGPreferredShares	3665865	usd
CY2022	icnb	Purchase And Retirement Of Treasury Stock PurchaseAndRetirementOfTreasuryStock	0	usd
CY2021	icnb	Purchase And Retirement Of Treasury Stock PurchaseAndRetirementOfTreasuryStock	-516528	usd
CY2022	icnb	Common Stock Issued To Settle Notes Payable CommonStockIssuedToSettleNotesPayable	0	usd
CY2021	icnb	Common Stock Issued To Settle Notes Payable CommonStockIssuedToSettleNotesPayable	4438708	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	2617474	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	3312739	usd
CY2022	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	189983	usd
CY2021	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	0	usd
CY2022	icnb	Conversion Of Series A2 Preferred Stock For Common Stock ConversionOfSeriesA2PreferredStockForCommonStock	3607	usd
CY2021	icnb	Conversion Of Series A2 Preferred Stock For Common Stock ConversionOfSeriesA2PreferredStockForCommonStock	0	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>1. ORGANIZATION AND NATURE OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Iconic Brands, Inc., (“the Company”, or “Iconic”), was incorporated in the State of Nevada on October 21, 2005. As of December 31, 2022, the subsidiaries of Iconic are wholly-owned TopPop LLC (“TopPop”) and United Spirits Inc., (“United”), 54% owned BiVi LLC (“BiVi”) and Bellissima Spirits LLC (“Bellissima”) and 60% owned Empire Wine and Spirits LLC (“Empire”) which was organized on February 4, 2022. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">BiVi is the brand owner of “BiVi 100 percent Sicilian Vodka,” and Bellissima is the brand owner of Bellissima sparkling wines. BiVi was organized in Nevada on May 4, 2015. Bellissima was organized in Nevada on November 23, 2015.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 26, 2021, the Company acquired 100% TopPop LLC (“TopPop”). TopPop is organized as a limited liability company in the State of New Jersey on September 5, 2019. TopPop’s primary operation is the manufacture and packaging of single-serve, shelf-stable, ready-to-freeze ice pops, both alcohols infused and non-alcoholic. TopPop began operations in December 2019 (see note 3). Also on July 26, 2021, the company purchased all the outstanding stock of United (see note 5).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Empire was organized in the State of Nevada on February 4, 2022. During the year ended December 31, 2022, Empire had no business activity or operations.</p>
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p>
CY2022Q4	us-gaap	Due From Banks DueFromBanks	596788	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	747141	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1055558	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2469592	usd
CY2022Q4	icnb	Potentially Dilutive Shares PotentiallyDilutiveShares	135500599	shares
CY2021Q4	icnb	Potentially Dilutive Shares PotentiallyDilutiveShares	32564030	shares
CY2022	icnb	Schedule Of Estimated Useful Lives Of Assetstextblock ScheduleOfEstimatedUsefulLivesOfAssetstextblock	<table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Schedule of estimated useful lives</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:25%;"/><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td/><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Years</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Machinery and equipment</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3 - 10</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Leasehold improvements</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Lesser of term of lease or useful life</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Furniture and fixtures</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3 - 5</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2021Q3	icnb	Additional Consideration Payments Cash And Stock AdditionalConsiderationPaymentsCashAndStock	3694273	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	26009600	shares
CY2021Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	10143744	usd
CY2021Q3	icnb	Shares Issued During Aquisition Per Share SharesIssuedDuringAquisitionPerShare	0.39
CY2021Q3	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	5042467	usd
CY2021Q3	icnb	Out Payment outPayment	0.45	pure
CY2022	icnb	Earn Out Amount First Year EarnOutAmountFirstYear	8244642	usd
CY2021Q3	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	11959863	usd
CY2022Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	0	usd
CY2022	icnb	Change In Fair Value Of The Contingent Consideration ChangeInFairValueOfTheContingentConsideration	20204505	usd
CY2021Q3	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.10	pure
CY2021Q3	icnb	Maturity Date MaturityDate	mature on July 26, 2022
CY2022	icnb	Desciption Of Cash Settlement DesciptionOfCashSettlement	3.55 million of these notes have agreed to extend the term until December 1, 2022
CY2022	us-gaap	Finite Lived Intangible Assets Purchase Accounting Adjustments FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments	15976877	usd
CY2022	us-gaap	Exploration Expense ExplorationExpense	3186453	usd
CY2021	us-gaap	Exploration Expense ExplorationExpense	1327614	usd
CY2022	icnb	Loss On Impairment Of Goodwill LossOnImpairmentOfGoodwill	15976877	usd
CY2022	icnb	Loss On Impairment Of Intangibles LossOnImpairmentOfIntangibles	17337933	usd
CY2021Q3	icnb	Percentage Of Shares Issued And Outstanding Acquired PercentageOfSharesIssuedAndOutstandingAcquired	1	pure
CY2021Q3	icnb	Shares Issued And Outstanding In Exchange For A Purchase Price SharesIssuedAndOutstandingInExchangeForAPurchasePrice	1000000	usd
CY2021Q3	us-gaap	Noncontrolling Interest In Variable Interest Entity NoncontrollingInterestInVariableInterestEntity	428465	usd
CY2022	icnb	Description Of Payment And Reduction DescriptionOfPaymentAndReduction	The $1,000,000 payment and the $428,465 reduction in noncontrolling interest are presented as a component of equity.
CY2022Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	8374753	usd
CY2021Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	5682583	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	912534	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	125619	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7462219	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5556964	usd
CY2021	us-gaap	Payments For Deposits PaymentsForDeposits	2480265	usd
CY2022	us-gaap	Depreciation Depreciation	791742	usd
CY2021	us-gaap	Depreciation Depreciation	119746	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1554693	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1228351	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5111079	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1367787	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	676195	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	780701	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	138796	usd
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	178013	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	204132	usd
CY2021Q4	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	88318	usd
CY2022Q4	icnb	Accrued Interest AccruedInterest	725601	usd
CY2021Q4	icnb	Accrued Interest AccruedInterest	215056	usd
CY2022Q4	icnb	Otheraccountspayableliabilitiescurrent Otheraccountspayableliabilitiescurrent	56637	usd
CY2021Q4	icnb	Otheraccountspayableliabilitiescurrent Otheraccountspayableliabilitiescurrent	83171	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6912440	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2713046	usd
CY2022	icnb	Schedule Of Debt Notes Payable ScheduleOfDebtNotesPayable	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance as of December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">28,458</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issuances of principal, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">976,708</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issued as consideration in TopPop acquisition</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,042,467</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Notes payable assumed in TopPop acquisition</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,927,380</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Payments on principal</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,315,380 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Settled with issuance of common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(4,438,708 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">PPP Forgiveness</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(28,458 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance as of December 31, 2021 </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,192,467</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Purchase of equipment with promissory note</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">189,983</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Payments toward promissory note</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(50,776 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance as of December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5,331,674</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2020Q4	us-gaap	Notes Payable NotesPayable	28458	usd
CY2021	icnb	Issuances Of Principal Net IssuancesOfPrincipalNet	976708	usd
CY2021	icnb	Issued In As Consideration In Toppop Acquisition IssuedInAsConsiderationInToppopAcquisition	5042467	usd
CY2021	icnb	Notes Payable Assumed In Toppop Acquisition NotesPayableAssumedInToppopAcquisition	5927380	usd
CY2021	icnb	Payments On Principalnotespayable PaymentsOnPrincipalnotespayable	-2315380	usd
CY2021	icnb	Settled With Issuance Of Common Stock SettledWithIssuanceOfCommonStock	-4438708	usd
CY2021	icnb	Ppp Forgiveness PppForgiveness	-28458	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	5192467	usd
CY2022	icnb	Purchase Of Equipment With Promissory Note PurchaseOfEquipmentWithPromissoryNote	189983	usd
CY2022	icnb	Payments Toward Promissory Note PaymentsTowardPromissoryNote	-50776	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	5331674	usd
CY2021	icnb	Issuances Of Principal Net IssuancesOfPrincipalNet	976708	usd
CY2021	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	30032	usd
CY2022Q4	icnb	Notes Payable Due One Year Or Less NotesPayableDueOneYearOrLess	5068915	usd
CY2022Q4	icnb	Notes Payable Due One To Two Years NotesPayableDueOneToTwoYears	29357	usd
CY2022Q4	icnb	Notes Payable Due Two To Three Years NotesPayableDueTwoToThreeYears	32200	usd
CY2022Q4	icnb	Notes Payable Due Three To Four Years NotesPayableDueThreeToFourYears	35332	usd
CY2022Q4	icnb	Notes Payable Due Four To Five Years NotesPayableDueFourToFiveYears	32676	usd
CY2022Q4	icnb	Notes Payable Due Five Years Or More NotesPayableDueFiveYearsOrMore	133194	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	5331674	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	93249	usd
CY2022	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	2273	usd
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q3	icnb	Preferred Stock Shares Designated PreferredStockSharesDesignated	45000	shares
CY2022Q1	icnb	Preferred Stock Shares Sold PreferredStockSharesSold	12258	shares
CY2022Q1	icnb	Preferred Stock Shares Designated PreferredStockSharesDesignated	4301004	shares
CY2022Q1	icnb	Warrants Issued To Purchase Shares Of Common Stock WarrantsIssuedToPurchaseSharesOfCommonStock	40018583	shares
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12200000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	11000000.0	usd
CY2021Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	26009600	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	10143744	usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3555	shares
CY2022Q4	icnb	Warrants Issued To Purchase Shares Of Common Stock WarrantsIssuedToPurchaseSharesOfCommonStock	14304880	shares
CY2022Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	2209517	shares
CY2021	icnb	Common Stock Expensed As Officers Compensation CommonStockExpensedAsOfficersCompensation	4861670	usd
CY2021	icnb	Common Stock Issuance Expenses CommonStockIssuanceExpenses	2226692	usd
CY2021	icnb	Option Awards Expenses OptionAwardsExpenses	242900	usd
CY2021	icnb	Retired Shares Warrants RetiredSharesWarrants	8283899	shares
CY2022Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	8810826	shares
CY2022Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.37
CY2022Q3	icnb	Restricted Common Stock RestrictedCommonStock	13000	shares
CY2021Q3	icnb	Warrants Issued To Purchase Shares Of Common Stock WarrantsIssuedToPurchaseSharesOfCommonStock	14304880	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022	icnb	Dividend Yield DividendYield	0	pure
CY2021	icnb	Dividend Yield DividendYield	0	pure
CY2022	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate	3.536	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0283	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.21	pure
CY2022	icnb	Expected Tax At21 And35 ExpectedTaxAt21And35	-6461438	usd
CY2021	icnb	Expected Tax At21 And35 ExpectedTaxAt21And35	-2196879	usd
CY2022	icnb	Nondeductible Stockbased Compensation NondeductibleStockbasedCompensation	0	usd
CY2021	icnb	Nondeductible Stockbased Compensation NondeductibleStockbasedCompensation	518614	usd
CY2022	icnb	Nondeductible Stock Based Compensation NondeductibleStockBasedCompensation	-887802	usd
CY2021	icnb	Nondeductible Stock Based Compensation NondeductibleStockBasedCompensation	0	usd
CY2022	icnb	State Tax Net Of Federal Benefit StateTaxNetOfFederalBenefit	-150250	usd
CY2021	icnb	State Tax Net Of Federal Benefit StateTaxNetOfFederalBenefit	-954062	usd
CY2022	icnb	Change In State Tax Rate ChangeInStateTaxRate	0	usd
CY2021	icnb	Change In State Tax Rate ChangeInStateTaxRate	-1077991	usd
CY2022	icnb	Other Taxes OtherTaxes	-3743	usd
CY2021	icnb	Other Taxes OtherTaxes	-174171	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	7503233	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3884489	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8172229	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4368423	usd
CY2022Q4	icnb	Stock Based Compensation StockBasedCompensation	4825198	usd
CY2021Q4	icnb	Stock Based Compensation StockBasedCompensation	4536393	usd
CY2022Q4	icnb	Intangibles Intangibles	4945009	usd
CY2021Q4	icnb	Intangibles Intangibles	-155470	usd
CY2022Q4	icnb	Accrued Compensation AccruedCompensation	-35187	usd
CY2021Q4	icnb	Accrued Compensation AccruedCompensation	-11049	usd
CY2022Q4	icnb	Right Of Use Assets RightOfUseAssets	-737468	usd
CY2021Q4	icnb	Right Of Use Assets RightOfUseAssets	39762	usd
CY2022Q4	icnb	Fixed Assets FixedAssets	-918004	usd
CY2021Q4	icnb	Fixed Assets FixedAssets	-29516	usd
CY2022Q4	icnb	Other Deferred Tax Assets OtherDeferredTaxAssets	-14503	usd
CY2021Q4	icnb	Other Deferred Tax Assets OtherDeferredTaxAssets	-14504	usd
CY2022Q4	icnb	Total Deferred Tax Assets TotalDeferredTaxAssets	16237274	usd
CY2021Q4	icnb	Total Deferred Tax Assets TotalDeferredTaxAssets	8734039	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16237274	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8734039	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	usd
CY2022	icnb	Percentage Of Valuation Allowance To Deferred Tax Asset PercentageOfValuationAllowanceToDeferredTaxAsset	1	pure
CY2022	icnb	Valuation Allowance Increase ValuationAllowanceIncrease	7503234	usd
CY2022	icnb	Federal Net Operating Loss FederalNetOperatingLoss	38154000	usd
CY2022	icnb	State Net Operating Loss StateNetOperatingLoss	19658000	usd
CY2022	icnb	Federal Net Operating Loss Expiring Amount FederalNetOperatingLossExpiringAmount	1521000	usd
CY2022	icnb	Federal Net Operating Loss Not Expiring Amount FederalNetOperatingLossNotExpiringAmount	36633000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due In Next Rolling Twelve Months FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths	1168312	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due In Rolling Year Two FinanceLeaseLiabilityPaymentsDueInRollingYearTwo	1201600	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due In Rolling Year Three FinanceLeaseLiabilityPaymentsDueInRollingYearThree	1235886	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due In Rolling Year Four FinanceLeaseLiabilityPaymentsDueInRollingYearFour	1271201	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due In Rolling Year Five FinanceLeaseLiabilityPaymentsDueInRollingYearFive	1248889	usd
CY2022Q4	icnb	Finance Lease Liability Payments Due In Rolling Year Six FinanceLeaseLiabilityPaymentsDueInRollingYearSix	325461	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due In Rolling After Year Five FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive	1099614	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	7550963	usd
CY2022Q4	icnb	Imputed Interest ImputedInterest	2124015	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	5426948	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5426948	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	4628734	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	10592867	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-10261585	usd
CY2021	us-gaap	Interest Expense InterestExpense	238607	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1487360	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3216315	usd
CY2022	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.10	pure
CY2022	icnb	Weighted Average Remaining Lease Term WeightedAverageRemainingLeaseTerm	P4Y10M24D
CY2022	us-gaap	Occupancy Net OccupancyNet	1085044	usd
CY2021	us-gaap	Occupancy Net OccupancyNet	424523	usd
CY2022	icnb	Qvc Direct Response Sales QvcDirectResponseSales	1172005	usd
CY2021	icnb	Qvc Direct Response Sales QvcDirectResponseSales	1599732	usd
CY2022	icnb	Other Other	2250531	usd
CY2021	icnb	Other Other	1112499	usd
CY2022	icnb	Total Bellissima TotalBellissima	3422536	usd
CY2021	icnb	Total Bellissima TotalBellissima	2712231	usd
CY2022	icnb	Top Up TopUp	11322725	usd
CY2021	icnb	Top Up TopUp	2192119	usd
CY2022	icnb	Hooters Product Line HootersProductLine	0	usd
CY2021	icnb	Hooters Product Line HootersProductLine	55666	usd
CY2022	icnb	Total Total	14745261	usd
CY2021	icnb	Total Total	4960016	usd
CY2022	icnb	Consulting Expense consultingExpense	182894	usd
CY2021	icnb	Consulting Expense consultingExpense	75000	usd
CY2022Q4	us-gaap	Assets Assets	18358748	usd
CY2022Q4	icnb	Total Liabilities TotalLiabilities	17998505	usd
CY2021Q4	us-gaap	Assets Assets	50706656	usd
CY2021Q4	icnb	Total Liabilities TotalLiabilities	31593601	usd
CY2022	us-gaap	Revenues Revenues	14745261	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	11213269	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	20448948	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-16916956	usd
CY2022	us-gaap	Interest Expense InterestExpense	792833	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	804696	usd
CY2022	icnb	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	20204505	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	15976877	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	-17337933	usd
CY2021	us-gaap	Revenues Revenues	4960016	usd
CY2022	icnb	Scheduleofunaudited Supplemental Pro Forma Datatextblock ScheduleofunauditedSupplementalProFormaDatatextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Year Ended </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sales</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:15%;vertical-align:bottom;text-align:right;">14,853,763</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cost of sales</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">11,077,756</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Gross Profit</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3,776,007</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">General and administrative expenses</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">11,123,461</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:10pt">Selling and marketing</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">998,741</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total Operating expenses</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">12,122,202</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Operating Loss</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">(8,346,195 </td><td style="vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other (Expense) Income</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Change in fair value of contingent consideration</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Loss on impairment of goodwill</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Loss on impairment of intangible assets</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interest expense</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">(448,024 </td><td style="vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Gain on forgiveness of PPP loan</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">(28,458 </td><td style="PADDING-BOTTOM: 1px;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total Other Expense</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">(476,482 </td><td style="PADDING-BOTTOM: 1px;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Net loss</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">(8,822,677 </td><td style="vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss attributable to noncontrolling interests in subsidiaries</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">(40,882 </td><td style="PADDING-BOTTOM: 1px;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend of common stock to preferred shareholders</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Net loss attributable to common and preferred shareholders:</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">(8,781,795 </td><td style="PADDING-BOTTOM: 3px;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Basic and Diluted Loss Per Common Share</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">(0.10 </td><td style="PADDING-BOTTOM: 3px;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Weighted Average Shares Outstanding – basic and diluted</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">87,715,476</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>

Files In Submission

Name	View Source	Status
0001477932-23-002106-index-headers.html	Edgar Link	pending
0001477932-23-002106-index.html	Edgar Link	pending
0001477932-23-002106.txt	Edgar Link	pending
0001477932-23-002106-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
icnb-20221231.xsd	Edgar Link	pending
icnb_10k.htm	Edgar Link	pending
icnb_ex14.htm	Edgar Link	pending
icnb_ex231.htm	Edgar Link	pending
icnb_ex311.htm	Edgar Link	pending
icnb_ex312.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
icnb-20221231_cal.xml	Edgar Link	unprocessable
icnb-20221231_def.xml	Edgar Link	unprocessable
icnb-20221231_pre.xml	Edgar Link	unprocessable
icnb-20221231_lab.xml	Edgar Link	unprocessable
icnb_10k_htm.xml	Edgar Link	completed
icnb_ex321.htm	Edgar Link	pending
icnb_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Iconic Brands, Inc.

2023 Q1 Form 10-K Financial Statement

#000147793223002106 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission